Insulin pen use for type 2 diabetes--a clinical perspective.
Diabetes Technol. Ther., Jun;12 Suppl 1:S86-90 (2010)
Analysis and perspective: A randomized, open-label, comparative crossover handling trial between two durable pens in patients with type 1 or 2 diabetes mellitus.
J Diabetes Sci Technol., Sep;5(5):1222-3 (2011)
Anti-4-1BB monoclonal antibodies abrogate T cell-dependent humoral immune responses in vivo through the induction of helper T cell anergy.
J. Exp. Med., Nov;190(10):1535-40 (1999)
Combination therapy for NIDDM with biosynthetic human insulin and glyburide.
Diabetes Care., Feb;15(2):265-9 (1992)
Characterization of a CD43/leukosialin-mediated pathway for inducing apoptosis in human T-lymphoblastoid cells.
J. Biol. Chem., Nov;271(44):27686-95 (1996)
Variation in aspects of cysteine proteinase catalytic mechanism deduced by spectroscopic observation of dithioester intermediates, kinetic analysis and molecular dynamics simulations.
Biochem. J., Jul;357(Pt 2):343-52 (2001)
Combination therapy with insulin and sulfonylureas for type II diabetes.
Diabetes Care., Jun;13(6):687-95 (1990)
Patterns of foot examination in a diabetes clinic.
Am. J. Med., Mar;78(3):371-4 (1985)
Recloning of SV40 early gene transfected human endothelial cells repeatedly recovers subpopulations with low passage characteristics and morphologies.
Biochem. Cell Biol., 72(3-4):117-25 (1994)